Dermata Therapeutics Inc
DRMA7.027USD
+0.347+5.20%
交易中 （美东）报价延迟15分钟
42.39M总市值
亏损市盈率 TTM
关于 Dermata Therapeutics Inc 公司
Dermata Therapeutics, Inc. 是一家后期医学皮肤病学公司。该公司专注于识别、开发和商业化用于治疗医学和美容皮肤病和疾病的药物候选产品。其两种候选产品 DMT310 和 DMT410 均采用其专有的多面 Spongilla 技术，用于局部治疗各种皮肤病。其主要候选产品 DMT310 旨在利用其 Spongilla 技术每周治疗一次各种皮肤病，其初始重点是治疗寻常痤疮，该病在美国的市场规模约为 5000 万患者。其第二种利用 Spongilla 技术的候选产品是 DMT410，即其组合疗法。DMT410 旨在包括一次使用其专有海绵粉的治疗，然后局部应用一次肉毒杆菌毒素以输送到真皮层。
公司简介
公司代码DRMA
公司名称Dermata Therapeutics Inc
上市日期Aug 13, 2021
CEOMr. Gerald T. (Gerry) Proehl
员工数量8
证券类型Ordinary Share
年结日Aug 13
公司地址3525 Del Mar Heights Rd., #322
城市SAN DIEGO
上市交易所NASDAQ Capital Market Consolidated
国家United States of America
邮编92130
电话18582230882
网址https://www.dermatarx.com/
公司代码DRMA
上市日期Aug 13, 2021
CEOMr. Gerald T. (Gerry) Proehl
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. David F. Hale
Mr. David F. Hale
Lead Independent Director
Lead Independent Director
8.15K
--
Ms. Kyri K. Van Hoose
Ms. Kyri K. Van Hoose
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
7.87K
--
Mr. Gerald T. (Gerry) Proehl
Mr. Gerald T. (Gerry) Proehl
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
110.00
--
Dr. Wendell Wierenga, Ph.D.
Dr. Wendell Wierenga, Ph.D.
Independent Director
Independent Director
26.00
--
Ms. Kathleen D. (Kathy) Scott
Ms. Kathleen D. (Kathy) Scott
Independent Director
Independent Director
12.00
--
Dr. Christopher J. Nardo, Ph.D.
Dr. Christopher J. Nardo, Ph.D.
Senior Vice President, Chief Development Officer
Senior Vice President, Chief Development Officer
11.00
--
Cliff Mastricola
Cliff Mastricola
Investor Relations
Investor Relations
--
--
Dr. Maria Bedoya Toro Munera, Ph.D.
Dr. Maria Bedoya Toro Munera, Ph.D.
Senior Vice President - Regulatory Affairs & Quality Assurance
Senior Vice President - Regulatory Affairs & Quality Assurance
--
--
Ms. Mary M. Fisher
Ms. Mary M. Fisher
Independent Director
Independent Director
--
--
Dr. Steven J. Mento, Ph.D.
Dr. Steven J. Mento, Ph.D.
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. David F. Hale
Mr. David F. Hale
Lead Independent Director
Lead Independent Director
8.15K
--
Ms. Kyri K. Van Hoose
Ms. Kyri K. Van Hoose
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
7.87K
--
Mr. Gerald T. (Gerry) Proehl
Mr. Gerald T. (Gerry) Proehl
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
110.00
--
Dr. Wendell Wierenga, Ph.D.
Dr. Wendell Wierenga, Ph.D.
Independent Director
Independent Director
26.00
--
Ms. Kathleen D. (Kathy) Scott
Ms. Kathleen D. (Kathy) Scott
Independent Director
Independent Director
12.00
--
Dr. Christopher J. Nardo, Ph.D.
Dr. Christopher J. Nardo, Ph.D.
Senior Vice President, Chief Development Officer
Senior Vice President, Chief Development Officer
11.00
--
收入明细
暂无数据
暂无数据
业务
地区
暂无数据
股东统计
更新时间: 8月2日 周六
更新时间: 8月2日 周六
持股股东
股东类型
持股股东
持股股东
占比
Proehl Investment Ventures LLC
12.54%
Armistice Capital LLC
6.44%
Fisher (Mary)
3.09%
Hale (David F)
1.28%
Van Hoose (Kyri K)
1.23%
Other
75.42%
持股股东
持股股东
占比
Proehl Investment Ventures LLC
12.54%
Armistice Capital LLC
6.44%
Fisher (Mary)
3.09%
Hale (David F)
1.28%
Van Hoose (Kyri K)
1.23%
Other
75.42%
股东类型
持股股东
占比
Corporation
12.54%
Hedge Fund
6.47%
Individual Investor
5.63%
Investment Advisor
1.10%
Investment Advisor/Hedge Fund
0.32%
Research Firm
0.24%
Other
73.71%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
27
1.68M
26.29%
+195.79K
2025Q1
28
1.68M
27.33%
+272.74K
2024Q4
32
78.09K
7.68%
+46.07K
2024Q3
33
30.60K
6.84%
-27.42K
2024Q2
35
56.93K
12.24%
+29.75K
2024Q1
37
29.18K
7.55%
-12.55K
2023Q4
38
44.19K
19.06%
+14.60K
2023Q3
41
30.91K
14.54%
-1.54K
2023Q2
41
33.48K
15.76%
+9.73K
2023Q1
38
19.00K
33.48%
-3.46K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Proehl Investment Ventures LLC
799.51K
12.54%
--
--
May 16, 2025
Armistice Capital LLC
411.00K
6.44%
+383.80K
+1411.03%
Mar 31, 2025
Fisher (Mary)
196.95K
3.09%
--
--
May 16, 2025
Hale (David F)
81.47K
1.28%
--
--
May 16, 2025
Van Hoose (Kyri K)
78.74K
1.23%
--
--
May 16, 2025
UBS Financial Services, Inc.
70.29K
1.1%
+56.42K
+406.63%
Mar 31, 2025
Geode Capital Management, L.L.C.
20.41K
0.32%
+12.00K
+142.70%
Mar 31, 2025
Edward Jones
12.00K
0.19%
+12.00K
--
Mar 31, 2025
Wells Fargo Advisors
2.00K
0.03%
-45.00
-2.20%
Mar 31, 2025
Tower Research Capital LLC
1.80K
0.03%
+402.00
+28.84%
Mar 31, 2025
查看更多
持股ETF
机构名称
占比
暂无数据
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
May 14, 2024
Merger
15<1
May 14, 2024
Merger
15<1
May 14, 2024
Merger
15<1
May 14, 2024
Merger
15<1
Mar 13, 2023
Merger
16<1
Mar 13, 2023
Merger
16<1
公告日期
类型
比率
May 14, 2024
Merger
15<1
May 14, 2024
Merger
15<1
May 14, 2024
Merger
15<1
May 14, 2024
Merger
15<1
Mar 13, 2023
Merger
16<1
Mar 13, 2023
Merger
16<1
Mar 13, 2023
Merger
16<1
Mar 13, 2023
Merger
16<1
